Recommended Topic Related To:

Caprelsa

"The U.S. Food and Drug Administration today approved Cometriq (cabozantinib) to treat medullary thyroid cancer that has spread to other parts of the body (metastasized).

Medullary thyroid cancer develops in cells in the thyroid gland that m"...

Caprelsa

OVERDOSE

In the event of an overdose, monitor patients closely for QTc prolongation. Because of the 19-day half-life, adverse reactions may not resolve quickly.

CONTRAINDICATIONS

Do not use in patients with congenital long QT syndrome [see BOXED WARNING].

Last reviewed on RxList: 4/10/2014
This monograph has been modified to include the generic and brand name in many instances.

A A A

Additional Caprelsa Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.